| ZYNE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ZYNE shares outstanding history going back to 8/5/2015:
Also see: ZYNE Market Cap History ZYNE YTD Return |
ZYNE Shares Outstanding History — Zynerba Pharmaceuticals Share Count Over Time
As of 8/9/2023 Zynerba Pharmaceuticals has 53.94 million ZYNE shares outstanding. Investors often track the ZYNE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ZYNE share count trends over time, with 35 historical shares outstanding datapoints presented, dating back to 8/5/2015.
| ZYNE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ZYNE Historical Shares Outstanding: +25.50% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ZYNE Stock Price Chart |
| About Zynerba Pharmaceuticals Inc |
| Zynerba Pharmaceuticals is engaged in pharmaceutically-produced transdermal cannabinoid therapies for neuropsychiatric disorders. Co. is focused on improving the lives of patients and their families living with severe, chronic health conditions including Fragile X syndrome (FXS), autism spectrum disorder (ASD), and 22q11.2 deletion syndrome (22q). Co. is developing Zygel, the pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol. Zygel is being developed as a clear gel with once- or twice-daily dosing and is targeting treatment of behavioral symptoms of FXS, ASD and 22q. We show 35 historical shares outstanding datapoints in our coverage of ZYNE's shares outstanding history. Understanding the changing numbers of ZYNE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ZYNE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ZYNE by allowing them to research ZYNE shares outstanding history as well as any other stock in our coverage universe. |
| ZYNE Current Stock Quote |
Quotes delayed 20 minutes  Free ZYNE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| ZYNE Share Performance |
| Shares Outstanding Peers |
| Zynerba Pharmaceuticals (ZYNE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ZYXI Shares Outstanding History A Shares Outstanding History AAC Shares Outstanding History AADI Shares Outstanding History AARD Shares Outstanding History ABAX Shares Outstanding History ABBV Shares Outstanding History ABC Shares Outstanding History ABEO Shares Outstanding History ABIO Shares Outstanding History More Healthcare companies » |
ZYNE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
